Q&A: Chordoma, a one in a million bone cancer
When you have a rare cancer that only affects one in a million people, it can be difficult to find the answers and information you need. That’s why we sat down with spinal neurosurgeon Laurence Rhines, M.D., and skull base neurosurgeon Shaan Raza, M.D., to discuss chordoma, a rare, malignant tumor diagnosed in about 300 people each year in the United States.
What is chordoma?
Chordoma is a bone cancer that belongs to the...
Cordotomy offers cancer pain relief in time for Boot Walk
On Saturday, Nov. 12, 2016, Kimberley Berry arrived at MD Anderson in her cowboy boots and Team Berry T-shirt, along with a dozen of her family...
Glioblastoma survivor keeps running
When Suzanne Stone completed her first half-marathon in February, the achievement was extra sweet: she’d managed to finish the long-distance...
8 brain tumor treatment questions, answered
A brain tumor diagnosis and treatment can bring many questions. That’s why John de Groot, M.D., co-leader of our Glioblastoma Moon Shot™, and Jeffrey Weinberg, M.D., recently took time to answer questions submitted online by brain tumor patients and caregivers.
Here are their responses to eight of the top questions we received about brain tumor treatment.
What treatment options are available for patients facing a brain tumor...
Laser interstitial thermal therapy gives relief to stage IV melanoma survivor
By the time Jennifer Weihe decided to try laser interstitial thermal therapy, or LITT, with neurosurgeon Ganesh Rao, M.D., she’d already been...
Cancer treatment side effect: Chemobrain
In the late 1990s, doctors began to pay attention to chemobrain, a term used by an increasing number of patients to describe mental symptoms...